Clinical Trial Update: IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia [Phase 1, Phase 2]

View source ↗

Summary

IMPAACT P1063 evaluated the safety and effectiveness of atorvastatin in HIV-infected children and adolescents with hyperlipidemia; the Phase 1/2 trial was termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hyperlipidemia

Drugs mentioned

• Atorvastatin (Lipitor) (Atorvastatin)

Snippet

Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group | Conditions: HIV Infections, Hyperlipidemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-04-06